Germline pathogenic variants among Mexican patients with adenocarcinoma of the pancreas

被引：0
|
作者：
Rodriguez Olivares, Jose Luis
Chavarri Guerra, Yanin
Arteaga, Jazmin
De la Mora Molina, Hector
Rodriguez-Faure, Andres
Maria Hernandez, Ana
Castillo, Danielle
Weitzel, Jeffrey N.
机构：
[1] Olivares, Mexico City, DF, Mexico
[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
[3] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Delegacion Tlalpan, Mexico
[4] Univ Autonoma Coahuila, Fac Med, Torreon, Mexico
[5] City Hope Canc Ctr, Duarte, CA USA
[6] Oncogenet Precis Prevent & Latin Amer Sch Oncol, Sierra Madre, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.540
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
540
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Pathogenic germline variants in hereditary cancer genes in patients with Multiple Myeloma
    Thibaud, Santiago
    Etra, Aaron
    Subaran, Ryan
    Soens, Zachry
    Newman, Scott
    Chen, Rong
    Chari, Ajai
    Cho, Hearn Jay
    Jagannath, Sundar
    Madduri, Deepu
    Melnekoff, David
    Richard, Shambavi
    Richter, Joshua
    Sanchez, Larysa
    Huang, Kuan-Lin
    Lagana, Alessandro
    Parekh, Samir
    Onel, Kenan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S73 - S73
  • [42] A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer
    Esteban Astiazaran-Symonds
    Alisa M. Goldstein
    Journal of Gastroenterology, 2021, 56 : 713 - 721
  • [43] Evaluation of bone health in breast cancer patients with germline pathogenic variants
    Isiklar, Aysun
    Basaran, Gul
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2023, 44 (05) : 148 - 152
  • [44] A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer
    Astiazaran-Symonds, Esteban
    Goldstein, Alisa M.
    JOURNAL OF GASTROENTEROLOGY, 2021, 56 (08) : 713 - 721
  • [45] Landscape of germline pathogenic variants beyond BRCA in pancreatic cancer patients
    Borea, R.
    Puccini, A.
    Andreotti, V.
    Pastorino, L.
    Vanni, I.
    Catalano, F.
    Puglisi, S.
    Bruno, W.
    Dalmasso, B.
    Signori, A.
    Fornarini, G.
    Ghiorzo, P.
    Sciallero, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S1093 - S1093
  • [46] Genetic testing and management of prostate cancer patients with pathogenic germline variants
    Katharina Reiter
    Melanie R. Hassler
    memo - Magazine of European Medical Oncology, 2024, 17 : 51 - 56
  • [47] Pathogenic germline variants in patients with endometrial cancer across diverse ancestries
    Liu, Ying L.
    Gordhandas, Sushmita
    Arora, Kanika
    Maio, Anna
    Kemel, Yelena
    Sheehan, Margaret
    Salo-Mullen, Erin E.
    Zhou, Qin
    Iasonos, Alexia
    Selenica, Pier
    Bandlamudi, Chaitanya
    Berger, Michael F.
    Abu-Rustum, Nadeem
    Ellenson, Lora H.
    Mandelker, Diana
    Offit, Kenneth
    Stadler, Zsofia Kinga
    Weigelt, Britta
    Aghajanian, Carol
    Brown, Carol L.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] Genetic testing and management of prostate cancer patients with pathogenic germline variants
    Reiter, Katharina
    Hassler, Melanie R.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2024, 17 (01) : 51 - 56
  • [49] Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma
    Santos, Maria
    Lanillos, Javier
    Maria Roldan-Romero, Juan
    Caleiras, Eduardo
    Montero-Conde, Cristina
    Cascon, Alberto
    Angel Climent, Miguel
    Anguera, Georgia
    Hernando, Susana
    Lainez, Nuria
    Robledo, Mercedes
    Robles, Luis
    de Velasco, Guillermo
    Garcia-Donas, Jesus
    Rodriguez-Antona, Cristina
    GENETICS IN MEDICINE, 2021, 23 (04) : 698 - 704
  • [50] Pathogenic germline mutations prevalence in Saudi patients with pancreatic ductal adenocarcinoma
    Algarni, Mohammed Ahmed
    Alshammari, Kanan
    Al Olayan, Ashwaq
    Sabatin, Fouad
    Mabsout, Nadine
    Zaher, Horya
    Shehata, Husam
    Al Turki, Saeed
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
12345